The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines
Abstract Background The accurate and timely publication of scientific findings is a key component of the global response to the COVID-19 pandemic. This article explores the role of Israeli researchers in the scientific literature regarding COVID-19 vaccines. Methods Content and bibliometric analysis...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-11-01
|
| Series: | Israel Journal of Health Policy Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13584-022-00548-3 |
| _version_ | 1811186933022326784 |
|---|---|
| author | Bruce Rosen Nadav Davidovitch Gabriel Chodick Avi Israeli |
| author_facet | Bruce Rosen Nadav Davidovitch Gabriel Chodick Avi Israeli |
| author_sort | Bruce Rosen |
| collection | DOAJ |
| description | Abstract Background The accurate and timely publication of scientific findings is a key component of the global response to the COVID-19 pandemic. This article explores the role of Israeli researchers in the scientific literature regarding COVID-19 vaccines. Methods Content and bibliometric analysis of articles included in the Web of Science database regarding COVID-19 vaccines, that were published between January 2020 and June 2022. Results The Web of Science includes 18,596 articles regarding COVID-19 vaccines that were published between January 2020 and June 2022. 536 (3%) of those articles had at least one Israeli author. These "Israeli articles" accounted for 11% of the NEJM articles on COVID-19 vaccines, 9% of such articles in Nature Medicine, and 4% of such articles in the Lancet. 80 of the 536 Israeli articles (15%) were recognized as "Highly Cited Papers" (articles that rank in the top 1% by citations for field and publication year). Most of the Israeli Highly Cited Papers (HCPs) analyzed the safety and/or efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech (BNT162b2). Most of the Israeli HCPs made use of detailed and comprehensive individual data available from Israel's health plans, hospitals, or Ministry of Health. The 15% HCP rate (i.e., the number of HCPs divided by the number of all articles) for the Israeli articles was triple the HCP rate for all articles on COVID-19 vaccines (5%). A key factor contributing to Israel's prominent role in rapid publication of vaccination impact studies was Israel's being a world leader in the initial vaccination rollout, the administration of boosters, and the vaccination of pregnant women. Other contributing factors include Israeli researchers' access to well-developed electronic health record systems linking vaccinations and outcomes, the analytic strengths of leading Israeli researchers and research institutions, collaborations with leading research institutions in other countries, and the ability to quickly identify emerging research opportunities and mobilize accordingly. Recent developments in the priorities and selection criteria of leading journals have also played a role; these include an increased openness to well-designed observational studies and to manuscripts from outside of Europe and North America. Conclusions Israeli researchers, Israeli research institutions, and the Israeli government can, and should, take concrete steps to build upon lessons learned in the course of the recent surge of high-quality publications related to COVID-19 vaccines (such as the value of linking data across organizations). These lessons can be applied to a wide range of fields, including fields that go well beyond vaccines and pandemic responses. |
| first_indexed | 2024-04-11T13:54:36Z |
| format | Article |
| id | doaj.art-2322800ef07349088e15f75df51069b8 |
| institution | Directory Open Access Journal |
| issn | 2045-4015 |
| language | English |
| last_indexed | 2024-04-11T13:54:36Z |
| publishDate | 2022-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Israel Journal of Health Policy Research |
| spelling | doaj.art-2322800ef07349088e15f75df51069b82022-12-22T04:20:24ZengBMCIsrael Journal of Health Policy Research2045-40152022-11-0111111610.1186/s13584-022-00548-3The role of Israeli researchers in the scientific literature regarding COVID-19 vaccinesBruce Rosen0Nadav Davidovitch1Gabriel Chodick2Avi Israeli3Myers-JDC-Brookdale InstituteSchool of Public Health, Faculty of Health Sciences, Ben-Gurion University of the NegevMaccabi Healthcare ServicesHebrew University Hadassah Medical SchoolAbstract Background The accurate and timely publication of scientific findings is a key component of the global response to the COVID-19 pandemic. This article explores the role of Israeli researchers in the scientific literature regarding COVID-19 vaccines. Methods Content and bibliometric analysis of articles included in the Web of Science database regarding COVID-19 vaccines, that were published between January 2020 and June 2022. Results The Web of Science includes 18,596 articles regarding COVID-19 vaccines that were published between January 2020 and June 2022. 536 (3%) of those articles had at least one Israeli author. These "Israeli articles" accounted for 11% of the NEJM articles on COVID-19 vaccines, 9% of such articles in Nature Medicine, and 4% of such articles in the Lancet. 80 of the 536 Israeli articles (15%) were recognized as "Highly Cited Papers" (articles that rank in the top 1% by citations for field and publication year). Most of the Israeli Highly Cited Papers (HCPs) analyzed the safety and/or efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech (BNT162b2). Most of the Israeli HCPs made use of detailed and comprehensive individual data available from Israel's health plans, hospitals, or Ministry of Health. The 15% HCP rate (i.e., the number of HCPs divided by the number of all articles) for the Israeli articles was triple the HCP rate for all articles on COVID-19 vaccines (5%). A key factor contributing to Israel's prominent role in rapid publication of vaccination impact studies was Israel's being a world leader in the initial vaccination rollout, the administration of boosters, and the vaccination of pregnant women. Other contributing factors include Israeli researchers' access to well-developed electronic health record systems linking vaccinations and outcomes, the analytic strengths of leading Israeli researchers and research institutions, collaborations with leading research institutions in other countries, and the ability to quickly identify emerging research opportunities and mobilize accordingly. Recent developments in the priorities and selection criteria of leading journals have also played a role; these include an increased openness to well-designed observational studies and to manuscripts from outside of Europe and North America. Conclusions Israeli researchers, Israeli research institutions, and the Israeli government can, and should, take concrete steps to build upon lessons learned in the course of the recent surge of high-quality publications related to COVID-19 vaccines (such as the value of linking data across organizations). These lessons can be applied to a wide range of fields, including fields that go well beyond vaccines and pandemic responses.https://doi.org/10.1186/s13584-022-00548-3IsraelVaccinationCOVID-19Publications |
| spellingShingle | Bruce Rosen Nadav Davidovitch Gabriel Chodick Avi Israeli The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines Israel Journal of Health Policy Research Israel Vaccination COVID-19 Publications |
| title | The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines |
| title_full | The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines |
| title_fullStr | The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines |
| title_full_unstemmed | The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines |
| title_short | The role of Israeli researchers in the scientific literature regarding COVID-19 vaccines |
| title_sort | role of israeli researchers in the scientific literature regarding covid 19 vaccines |
| topic | Israel Vaccination COVID-19 Publications |
| url | https://doi.org/10.1186/s13584-022-00548-3 |
| work_keys_str_mv | AT brucerosen theroleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT nadavdavidovitch theroleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT gabrielchodick theroleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT aviisraeli theroleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT brucerosen roleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT nadavdavidovitch roleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT gabrielchodick roleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines AT aviisraeli roleofisraeliresearchersinthescientificliteratureregardingcovid19vaccines |